Top News

Isis Pharmaceuticals Gets $10M From Biogen Idec

Carlsbad-based Isis Pharmaceuticals, which is developing antisense technology for a wide range of conditions, said it has earned $10M in a milestone payment from Biogen Idec today. Isis Pharmaceuticals said the payment is associated with the validation of an undisclosed target to treat a neurological disorder. The two have multiple programs together, where Biogen Idec is tapping Isis PHarmceuticals' antisense technology.


 

Marketplace


 

 

Latest Headlines

Browse Issues

 
 

Keep up with all of the latest Southern California high tech news via email (it's free!)



or Cancel